FindMyKOL
Clinical trialNCT00631540CompletedInterventional

REFORM Clinical Study: Treatment of Renal Artery Stenosis With the Formula Balloon-Expandable Stent

NCT00631540 is an interventional trial sponsored by Cook Group Incorporated. As of 21 Nov 2026, it is completed. It studies Renal Artery Stenosis. The registry lists an enrollment of 100 participants at 7 sites in 1 country. The registry lists a start date of 29 Feb 2008 and a primary completion date of 31 May 2010.

SponsorCook Group IncorporatedEnrollment100Renal Artery Stenosis
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT00631540
FieldValue
Registry IDNCT00631540
StatusCompleted
Study typeInterventional trial
Lead sponsorCook Group Incorporated
Enrollment100
Registered sites7
Countries1
ConditionsRenal Artery Stenosis
Start29 Feb 2008
Primary completion31 May 2010
Study completion31 May 2012
Last update posted16 Dec 2013

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of the study is to evaluate the safety and effectiveness of the Formula Balloon-Expandable Stent in treatment of renal artery stenosis.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Florida, United States2 sites
  • Munroe Regional Medical Center

    Ocala

  • Orlando Regional Medical Center

    Orlando

New York, United States1 site
  • Lenox Hill Hospital

    New York

North Carolina, United States1 site
  • Wake Med Raleigh Campus

    Raleigh

Ohio, United States1 site
  • Fairfield Medical Center

    Lancaster

Pennsylvania, United States1 site
  • Pinnacle Health at Harrisburg

    Harrisburg

Washington, United States1 site
  • Swedish Medical Center

    Seattle

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashington: 1 siteWA1MontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew York: 1 siteNY1MassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhio: 1 siteOH1Pennsylvania: 1 sitePA1New JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth Carolina: 1 siteNC1South CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFlorida: 2 sitesFL2District of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT00631540

Each answer restates registry values shown on this page.

What is NCT00631540?

NCT00631540 is an interventional trial sponsored by Cook Group Incorporated. It studies Renal Artery Stenosis.

Who leads NCT00631540?

The registry names Robert Bersin, MD (principal investigator, Swedish Medical Center) as the overall official.

Where does NCT00631540 run?

The registry lists 7 sites in 1 country. Every site with a stated country is in one country: United States.

When did NCT00631540 end?

The registry lists a primary completion date of 31 May 2010 and a study completion date of 31 May 2012. The sponsor last updated the record on 16 Dec 2013.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.